In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and
• 1.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit. Learners who opt-in by providing their Board ID and DOB (MM/DD) will be automatically reported.

This program is acceptable for 1.25 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-25-024-H01-P, effective 12/31/2025. This is a knowledge-based activity, and there is no fee to attend.

*IMPORTANT* Pharmacists MUST request credit within 60 days of activity completion. Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks. 

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME. 

This enduring material is approved for 1 year from the date of original release, December 31, 2025, to December 30, 2026.

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development. 

Faculty report the following relevant financial relationship(s)

Jaime Almandoz, MD, MBA, FTOS

• Consultant: AbbVie, Amgen, Boehringer Ingelheim, Kailera, Lilly, Nestle, Novo Nordisk, Rivus, Rhythm

Deborah B. Horn, DO, MPH, MFOMA

• Advisor: Amgen, AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk, Zealand
• Consultant: Amgen, AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk, Zealand
• Speaker Contracted by Ineligible Company: Lilly, Novo Nordisk
• Independent Research Contractor (paid to institution): KVK Tech, Lilly, Novo Nordisk, Weight Watchers

Robert F. Kushner, MD, MS, FACP, FTOS, DABOM

• Advisor: AbbVie, Altimmune, Antag, AstraZeneca, Boehringer Ingelheim, Currax, Lilly, Novo Nordisk, Regeneron, Structure, Weight Watchers
• Speaker Contracted by Ineligible Company: Novo Nordisk

Domenica Rubino, MD

• Advisor: AbbVie, AstraZeneca, Boehringer Ingelheim, Cytoki, Ferring, Lilly, Neurocrine, Novo Nordisk, Pfizer, Regeneron, Roche, Shionogi
• Consultant: AbbVie, AstraZeneca, Boehringer Ingelheim, Cytoki, Ferring, Lilly, Neurocrine, Novo Nordisk, Pfizer, Regeneron, Roche, Shionogi
• Speaker Contracted by Ineligible Company: Novo Nordisk
• Independent Research Contractor: Amgen, AstraZeneca, Boehringer Ingelheim, Novo Nordisk
• Individual Stocks (publicly traded): AbbVie

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose. 

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose. 

Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose. 

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 67% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or CPE Statement of Credit.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application. US Physicians who opt-in by providing their medical license number, state of licensure, and date of birth will have their credits automatically reported to the ACCME. 

*IMPORTANT* Pharmacists MUST request credit within 60 days of activity completion. Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks. 

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2025 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product. 

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:

• Specify the copyrighted work you believe has been infringed upon.
• Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
• Share your name, address, telephone number, and, if available, your email address.
• Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
• Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
• Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
[email protected]
or call: 856-994-9400, ext. 614